July 5, 2011
1. Will Biologics Revolutionize Sports Medicine?: 4 Physician Responses.
2. Medtronic CEO Omar Ishrak Defends Medtronic, Infuse.
3. 10 Statistics on Orthopedic Surgeon Compensation in 2010.
4. Register Now for the Best Annual ASC Business, Legal and Clinical Conference: The 18th Annual Ambulatory Surgery Centers Conference--Improving Profitabliy and Business and Legal Issues, Oct. 27-29, Chicago. To learn more and register, .
5. 12 Orthopedic Surgeries Performed on Major League Baseball Players.
6. AAOS: 4 Tips for Orthopedic Practices Using Corporate Credit Cards.
7. Stryker, Smith & Nephew, Arthrex Top Arthroscopy and Soft Tissue Market.
8. Aesculap Launches Spine Trauma, Oncologic Surgical System.
9. Cayenne Medical Launches CrossFix II Meniscal Repair System.
10. Generalists Should Handle Most Pain Cases, Says IOM Report.
Orthopedic and Spine Device Industry Stock Watch--Opening Prices Up Vs. Week Ago for Stryker, Zimmer & Smith & Nephew: Stryker, $60.03; Zimmer Holdings, $64.90; Smith & Nephew, $54.18; Medtronic, $38.57.
Learn more about the other Becker's publications: Becker's ASC Review and Becker's Hospital Review.
Learn More About Our Featured E-Weekly Advertisers: Blue Chip, Practice Partners in Healthcare and Amedica.
|